The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease

来源 :神经科学通报(英文版) | 被引量 : 0次 | 上传用户:qixiannu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
IntroductionrnThe mitochondrion is a double-membrane organelle consisting of an outer membrane,intermembrane space,inner membrane,cristae,and matrix.It is the “energy plant” that provides most of the energy for cells.Mitochondria also participate in various processes such as calcium homeostasis,cell death,and cell growth during development and aging [1].Mitochondrial abnormalities are a common phenomenon in aging and age-related neurodegenerative diseases such as Alzheimer\'s disease (AD).Mitochondrial dysfunction is even taken to be a marker for aging,an indispensable risk factor for AD [1].Anti-oxidants and factors that maintain mitochondrial homeostasis have beneficial effects in AD therapy.Thus,the mitochondrion is emerging as a novel target for AD therapy.
其他文献
Dear Editor,rnParkinson\'s disease (PD) is the second most common neurodegenerative disease in the elderly [1,2].PD affects 1%-2% of the world\'s population older than 65 years [3-5].In recent years,large-scale genome-wide association studies (GWAS) h
期刊